← All Sponsors
SPONSOR

Fujian Akeylink Biotechnology Co., Ltd.

Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: Chronic Hepatitis B
NCT06263959 Phase 2
Recruiting

A Randomized, Double-blind, Placebo-controlled Phase IIa Clinical Study to Evaluate the Safety and Efficacy of GST-HG131 Tablets in Patients With Chronic Hepatitis B

Chronic Hepatitis B
China View Trial →